Klyachko K A, Schuldiner S, Neyfakh A A
Department of Medicinal Chemistry and Pharmacognosy, University of Illinois, Chicago 60607, USA.
J Bacteriol. 1997 Apr;179(7):2189-93. doi: 10.1128/jb.179.7.2189-2193.1997.
The Bacillus subtilis multidrug transporter Bmr, a member of the major facilitator superfamily of transporters, causes the efflux of a number of structurally unrelated toxic compounds from cells. We have shown previously that the activity of Bmr can be inhibited by the plant alkaloid reserpine. Here we demonstrate that various substitutions of residues Phe143 and Phe306 of Bmr not only reduce its sensitivity to reserpine inhibition but also significantly change its substrate specificity. Cross-resistance profiles of bacteria expressing mutant forms of the transporter differ from each other and from the cross-resistance profile of cells expressing wild-type Bmr. This result strongly suggests that Bmr interacts with its transported drugs directly, with residues Phe143 and Phe306 likely to be involved in substrate recognition.
枯草芽孢杆菌多药转运蛋白Bmr是转运蛋白主要易化子超家族的成员之一,可使多种结构不相关的有毒化合物从细胞中流出。我们之前已经表明,Bmr的活性可被植物生物碱利血平抑制。在此我们证明,Bmr的苯丙氨酸143(Phe143)和苯丙氨酸306(Phe306)残基的各种取代不仅降低了其对利血平抑制的敏感性,还显著改变了其底物特异性。表达转运蛋白突变形式的细菌的交叉耐药谱彼此不同,也与表达野生型Bmr的细胞的交叉耐药谱不同。这一结果强烈表明,Bmr与其转运的药物直接相互作用,苯丙氨酸143和苯丙氨酸306残基可能参与底物识别。